Conventus Orthopaedics closed a US $12MM venture loan. Funds will support commercialization of Nitinol-based cage technology, used to treat periarticular fractures.
Articulus Bio received an undisclosed amount of funding that will support development of a total ankle replacement specifically addressing the issue of wear debris.
Zimmer Biomet announced positive results in a pilot study demonstrating safety and promising efficacy from use of the nSTRIDE® Autologous Protein Solution Kit to treat knee OA.